Anti-atherogenic mechanisms of semaglutide Studies to elucidate the cardiovascular protection mechanisms of GLP-1 have been conducted over the years, but they are not completely understood
However, conclusive research remains scant not least as pregnancy or intention to become pregnant were exclusion criteria in initial clinical trials of such drugs
Watching for Signs of Improved Fertility In women with conditions like PCOS, weight loss and better hormone balance from tirzepatide treatment may increase the chances of ovulation and pregnancy
Comparative Risk: In patients with Type 2 Diabetes, GLP-1 RA use was associated with a 7% lower cancer incidence compared with DPP4 inhibitors
If you are struggling with current GLP-1 therapies, see not losing weight on semaglutide or why am I not losing weight on tirzepatide
This formula is based on the standard concentration of semaglutide, which is typically 20 units per milligram